Literature DB >> 9528954

Activation of transcriptionally active nuclear factor-kappaB by tumor necrosis factor-alpha and its inhibition by antioxidants in rat thyroid FRTL-5 cells.

T Kikumori1, F Kambe, T Nagaya, T Imai, H Funahashi, H Seo.   

Abstract

ABSTRACT Tumor necrosis factor-alpha (TNF-alpha) exerts pleiotropic effects on thyroid follicular cells. However, the intracellular signaling pathway for the TNF-alpha action has not been well elucidated. The present study examined the effects of TNF-alpha on the activation of nuclear factor-kappa B (NF-kappaB) and on the expression of interleukin (IL)-6 gene in rat thyroid FRTL-5 cells. The treatment of the cells with TNF-alpha resulted in the nuclear translocation of p65-p50 heterodimer as well as p50-p50 homodimer NF-kappaBs. The treatment with the antioxidants 20 mM N-acetyl-L-cysteine (NAC) and 10 microM pyrrolidine dithiocarbamate (PDTC) inhibited the TNF-alpha-dependent activation of p65-p50 heterodimer but not the p50-p50 homodimer, indicating that generation of oxidants is required for the activation of the heterodimer NF-kappaB. When the plasmid containing the multimerized NF-kappaB sites upstream of a luciferase reporter gene was transfected into FRTL-5 cells, the treatment with NAC or PDTC prevented the TNF-alpha-dependent increase in the luciferase activities, indicating that the p65-p50 heterodimer is a transcriptionally active NF-kappaB. Accordingly, the TNF-alpha-dependent increase in IL-6 messenger RNA and in secretion of the protein was prevented by the treatment with NAC. These results strongly suggest that TNF-alpha increases the IL-6 gene expression through the activation of NF-kappaB in the thyroid cells, and that antioxidants suppress the TNF-alpha-dependent IL-6 expression by inhibiting the activation of the transcriptionally active NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9528954     DOI: 10.1210/endo.139.4.5874

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  A potential role of activated NF-kappa B in the pathogenesis of euthyroid sick syndrome.

Authors:  T Nagaya; M Fujieda; G Otsuka; J P Yang; T Okamoto; H Seo
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  Osteoblast-like differentiation of cultured human coronary artery smooth muscle cells by bone morphogenetic protein endothelial cell precursor-derived regulator (BMPER).

Authors:  Seimi Satomi-Kobayashi; Mitsuo Kinugasa; Reiko Kobayashi; Kinta Hatakeyama; Yusuke Kurogane; Tatsuro Ishida; Noriaki Emoto; Yujiro Asada; Yoshimi Takai; Ken-ichi Hirata; Yoshiyuki Rikitake
Journal:  J Biol Chem       Date:  2012-07-09       Impact factor: 5.157

3.  Thyrotropin modifies activation of nuclear factor kappaB by tumour necrosis factor alpha in rat thyroid cell line.

Authors:  T Kikumori; F Kambe; T Nagaya; H Funahashi; H Seo
Journal:  Biochem J       Date:  2001-03-15       Impact factor: 3.857

4.  A fusion-protein approach enabling mammalian cell production of tumor targeting protein domains for therapeutic development.

Authors:  Jia Hu; Xiang Chen; Xuhua Zhang; Xiaopeng Yuan; Mingjuan Yang; Hui Dai; Wei Yang; Qinghua Zhou; Weihong Wen; Qirui Wang; Weijun Qin; Aizhi Zhao
Journal:  Protein Sci       Date:  2018-04-14       Impact factor: 6.725

5.  Oxygen-evoked changes in transcriptional activity of the 5'-flanking region of the human amiloride-sensitive sodium channel (alphaENaC) gene: role of nuclear factor kappaB.

Authors:  Deborah L Baines; Mandy Janes; David J Newman; Oliver G Best
Journal:  Biochem J       Date:  2002-06-01       Impact factor: 3.857

6.  Respiratory syncytial virus and TNF alpha induction of chemokine gene expression involves differential activation of Rel A and NF-kappa B1.

Authors:  Laura R Carpenter; James N Moy; Kenneth A Roebuck
Journal:  BMC Infect Dis       Date:  2002-03-28       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.